Clinical trial
Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome
NCT00492882 · University Hospital, Lille, Other · Completed
Key facts
| NCT number | NCT00492882 |
|---|---|
| Title | Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome |
| Official title | Dynamic Changes in the Serum Anti-Müllerian Hormone Level During Low-Dose recFSH Administration Further Support Its Role in the Anovulation of Polycystic Ovary Syndrome |
| Acronym | SOPK |
| Lead sponsor | University Hospital, Lille, Other |
| Collaborators | Organon Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Anovulation |
| Intervention type | Drug |
| Interventions | usual administration of exogenous recombinant FSH |
| Enrollment | 30 |
| Start date | Nov 1, 2003 |
| Completion | Jan 1, 2007 |
| First posted | Jun 27, 2007 |
| Last update posted | Jun 27, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: